The potential use of Toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents.
about
Metal-Based Nanoparticles and the Immune System: Activation, Inflammation, and Potential ApplicationsStructural dynamic analysis of apo and ATP-bound IRAK4 kinaseIdentification of novel synthetic toll-like receptor 2 agonists by high throughput screening.Type I interferon drives dendritic cell apoptosis via multiple BH3-only proteins following activation by PolyIC in vivo.Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant.Paradoxical decrease in the capture and lymph node delivery of cancer vaccine antigen induced by a TLR4 agonist as visualized by dual-mode imaging.Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress.The battle between virus and host: modulation of Toll-like receptor signaling pathways by virus infection.Toll-like receptors as potential therapeutic targets in cardiac dysfunction.Toll-like receptor modulators: a patent review (2006-2010).Modulation of γδ T cell responses by TLR ligands.Stimulating natural killer cells to protect against cancer: recent developments.Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis.Toll gates: An emerging therapeutic target.Poly(I:C) potentiates Bacillus Calmette-Guérin immunotherapy for bladder cancer.Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis.Targeted liposomal drug delivery to monocytes and macrophagesToll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease
P2860
Q28396375-560317B9-CD69-400F-808A-5797A020D5D1Q30584224-F388EE7D-5CE2-40EB-BE73-46DA499B9D12Q33588328-556071F6-B1D7-443B-8EB4-D06293D1A429Q33933053-12E1557C-3101-494F-8F93-D4E3192B3004Q34022013-2E2F4377-7CE1-4EEC-AC3B-02CC9454607DQ34995056-2F2B5392-9A18-4627-BC58-9CE37D39CED2Q37498989-86B52E02-B8F5-4B58-ADA0-56FB1A1E70E2Q37776665-293DFD14-8142-40F5-B114-04366E5CDFEDQ37850809-E2F037C7-2E9C-42B8-8C0B-D2D306973450Q37853197-D8C34474-CEC8-47FA-8939-EBC5FE623D6FQ37874203-4D4FF73D-7E32-4D78-97D9-C77CFA39951DQ37877269-BF040C85-D411-488A-BD03-9076E9D35D5DQ37943809-5420D239-7CC2-4D7B-89DD-B2B6155EC76CQ38333830-B2BAFF7E-8628-483B-B5CE-F639215ACF3CQ38804315-2DE258AF-A8E0-4C82-A58E-A727D5DCC3F8Q41180997-2A71F8F5-1D52-4079-987C-AA437A1A9008Q42108171-8716E03B-396B-4DDD-B254-FD8D4D89D21EQ59130037-AF07C341-C7E3-4836-9CCC-6DDE9AAE571B
P2860
The potential use of Toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The potential use of Toll-like ...... tic and/or therapeutic agents.
@en
The potential use of Toll-like receptor
@nl
type
label
The potential use of Toll-like ...... tic and/or therapeutic agents.
@en
The potential use of Toll-like receptor
@nl
prefLabel
The potential use of Toll-like ...... tic and/or therapeutic agents.
@en
The potential use of Toll-like receptor
@nl
P2860
P1476
The potential use of Toll-like ...... tic and/or therapeutic agents.
@en
P2093
Alexander M Abdelnoor
Amani Makkouk
P2860
P304
P356
10.1080/08923970902802926
P577
2009-01-01T00:00:00Z